Oncology sponsored testing program 

Invitae partners with biopharma companies to offer sponsored testing for patients who meet eligibility criteria

Invitae Detect Hereditary Prostate Cancer

The Detect Hereditary Prostate Cancer genetic testing program provides sponsored, no-charge genetic testing and counseling for individuals diagnosed with prostate cancer stage II and above.

Prostate cancer is the leading cancer in males. An estimated 174,000 patients are newly diagnosed each year in the U.S. The Detect Hereditary Prostate Cancer program is designed to determine the germline genetic etiology of prostate cancer to evaluate precision medical and surgical treatment options.